Benitec Biopharma Inc. (BNTC) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $18.0K | -89.9% |
| 2024 | $179.0K | +17800.0% |
| 2023 | $1.0K | -92.3% |
| 2022 | $13.0K | -94.1% |
| 2021 | $221.0K | +132.6% |
| 2020 | $95.0K | -76.5% |
| 2019 | $404.0K | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $18.0K | -89.9% |
| 2024 | $179.0K | +17800.0% |
| 2023 | $1.0K | -92.3% |
| 2022 | $13.0K | -94.1% |
| 2021 | $221.0K | +132.6% |
| 2020 | $95.0K | -76.5% |
| 2019 | $404.0K | — |